ORTHOPEDIATRICS CORP
KIDSNASDAQTrading Snapshot
- Day Range
- $22.68 – $22.91
- 52-Week Range
- $14.42 – $26.74
- Volume
- $3.08B
- Avg Volume
- $3.07B
- Shares Outstanding
- 25.7M
- Next Earnings
- Nov 11, 2026
Fundamentals Snapshot
- Annual Revenue
- $236M
- Last Q Revenue
- $71M
- P/E Ratio
- -13.5
- P/S Ratio
- 2.3x
- EPS (TTM)
- $-1.66
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +1.7%
Why Investors Own KIDS
- ✓High-growth profile — revenue up +50.5% YoY with expanding US Equity exposure.
- ✓Healthy economics — 59% gross margin and 20% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
ORTHOPEDIATRICS CORP
KIDS
StockOtter · stockotter.spaceAbout ORTHOPEDIATRICS CORP
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
OrthoPediatrics Surpasses 1,000 PNP Tibia Nail Implantations
WARSAW, Ind., Sept. 22, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced t
OrthoPediatrics Corp (KIDS) Stock Down 6.0% -- Now Undervalued? GF Score: 84/100
On September 17, 2026, OrthoPediatrics Corp (KIDS) shares fell 6.0%, bringing the current price to $21.78. The stock has seen a 52-week range of $14.42 to $26.7
ICE Launches Private Credit Reference Data Service
Intercontinental Exchange, Inc. (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets, today
Jennifer Pritzker Sells 302,369 Shares of OrthoPediatrics (NASDAQ:KIDS) Stock
OrthoPediatrics Corp. (NASDAQ: KIDS - Get Free Report) major shareholder Jennifer Pritzker sold 302,369 shares of the stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average pri
Insider Selling: OrthoPediatrics (NASDAQ:KIDS) Director Sells $6,352,772.69 in Stock
OrthoPediatrics Corp. (NASDAQ: KIDS - Get Free Report) Director David Pelizzon sold 302,369 shares of OrthoPediatrics stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $21.01
Squadron Capital Llc Sells 302,369 Shares of OrthoPediatrics (NASDAQ:KIDS) Stock
OrthoPediatrics Corp. (NASDAQ: KIDS - Get Free Report) major shareholder Squadron Capital Llc sold 302,369 shares of OrthoPediatrics stock in a transaction on Thursday, September 10th. The shares were sold at an average